Atika Capital Management LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
Atika Capital Management LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2019$2,696,000
-4.3%
32,000
-15.1%
0.52%
-12.1%
Q3 2019$2,818,000
+35.1%
37,690
+14.2%
0.59%
+44.6%
Q2 2019$2,086,000
-25.3%
32,990
-43.1%
0.41%
-27.8%
Q1 2019$2,793,000
+37.9%
58,000
-4.1%
0.57%
-4.7%
Q4 2018$2,026,000
-80.4%
60,500
-69.3%
0.60%
-67.8%
Q3 2018$10,323,000
+266.5%
197,000
+118.9%
1.85%
+241.5%
Q2 2018$2,817,000
+671.8%
90,000
+257.1%
0.54%
+145.2%
Q1 2016$365,00025,2000.22%
Other shareholders
NOVOCURE LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$24,386,00014.72%
HARTLINE INVESTMENT CORP/ 335,191$58,001,0008.32%
Deep Track Capital, LP 1,341,300$93,220,0006.13%
MORGAN JESS S & CO INC 48,345$3,360,0003.48%
Taylor Frigon Capital Management LLC 68,908$4,789,0002.49%
HighVista Strategies LLC 28,007$1,946,0001.18%
Private Harbour Investment Management & Counsel, LLC 13,106$911,0001.01%
Lloyd Park, LLC 9,325$648,0000.68%
Baillie Gifford 9,116,230$633,578,0000.65%
HAP Trading, LLC 110,900$10,575,0000.53%
View complete list of NOVOCURE LTD shareholders